Current research suggests that gain‐of‐function mutations in ITGA2B or ITGB3 underlie the pathogenesis of most ITGA2B/ITGB3‐related macrothrombocytopenia and mechanistically distinguish it from classical GT. The gene discussed is ITGB3; the disease is Macrothrombocytopenia.